Paper26730486
The potential of liquid biopsies.
Buder A and 2 others. Curr Opin Oncol, 2016. Cited by 51 papers, by iCite.
Cite this record
ConductScience Library. The potential of liquid biopsies. Papers, record 26730486. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/26730486
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics11
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Biomarkers, Tumor | Major topic |
| Carcinoma, Non-Small-Cell Lung | Major topic |
| DNA, Neoplasm | Major topic |
| Lung Neoplasms | Major topic |
| Antineoplastic Agents | |
| ErbB Receptors | |
| Exosomes | |
| Humans | |
| Neoplastic Cells, Circulating | |
| Protein Kinase Inhibitors | |
| Tumor Burden |
Source PubMed
Cited by35
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 51 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 39775010 | Comparative analysis of EGFR mutations in circulating tumor DNA and primary tumor tissues from lung cancer patients using BEAMing PCR. | Sci Rep | 2025 | https://conductscience.org/library/papers/39775010 | PubMed |
| 37450123 | Role of Liquid Biopsies in Rheumatoid Arthritis. | Methods Mol Biol | 2023 | https://conductscience.org/library/papers/37450123 | PubMed |
| 37450116 | Diagnosis, Monitoring, and Prognosis of Liquid Biopsy in Cancer Immunotherapy. | Methods Mol Biol | 2023 | https://conductscience.org/library/papers/37450116 | PubMed |
| 37444638 | Epidermal Growth Factor Receptor T790M Mutation Testing in Non-Small Cell Lung Cancer: An International Collaborative Study to Assess Molecular EGFR T790M Testing in Liquid Biopsy. | Cancers (Basel) | 2023 | https://conductscience.org/library/papers/37444638 | PubMed |
| 36768828 | Liquid Biopsy for Lung Cancer: Up-to-Date and Perspectives for Screening Programs. | Int J Mol Sci | 2023 | https://conductscience.org/library/papers/36768828 | PubMed |
| 35582281 | Liquid biopsies in myeloid malignancies. | Cancer Drug Resist | 2019 | https://conductscience.org/library/papers/35582281 | PubMed |
| 34514090 | Progress and application of circulating tumor cells in non-small cell lung cancer. | Mol Ther Oncolytics | 2021 | https://conductscience.org/library/papers/34514090 | PubMed |
| 34445645 | Cell-Free DNA in Rheumatoid Arthritis. | Int J Mol Sci | 2021 | https://conductscience.org/library/papers/34445645 | PubMed |
| 33995103 | Extracellular Vesicles: A Novel Tool Facilitating Personalized Medicine and Pharmacogenomics in Oncology. | Front Pharmacol | 2021 | https://conductscience.org/library/papers/33995103 | PubMed |
| 33919291 | Somatic Copy-Number Alterations in Plasma Circulating Tumor DNA from Advanced EGFR-Mutated Lung Adenocarcinoma Patients. | Biomolecules | 2021 | https://conductscience.org/library/papers/33919291 | PubMed |
| 33918661 | Circulating Biomarkers of Response and Toxicity of Immunotherapy in Advanced Non-Small Cell Lung Cancer (NSCLC): A Comprehensive Review. | Cancers (Basel) | 2021 | https://conductscience.org/library/papers/33918661 | PubMed |
| 33642890 | Detection of EGFR Activating and Resistance Mutations by Droplet Digital PCR in Sputum of EGFR-Mutated NSCLC Patients. | Clin Med Insights Oncol | 2021 | https://conductscience.org/library/papers/33642890 | PubMed |
| 33352935 | Circulating Exosomal MicroRNA-1307-5p as a Predictor for Metastasis in Patients with Hepatocellular Carcinoma. | Cancers (Basel) | 2020 | https://conductscience.org/library/papers/33352935 | PubMed |
| 32537885 | Exosomal microRNA-4661-5p-based serum panel as a potential diagnostic biomarker for early-stage hepatocellular carcinoma. | Cancer Med | 2020 | https://conductscience.org/library/papers/32537885 | PubMed |
| 32420063 | EGFR mutation tracking predicts survival in advanced EGFR-mutated non-small cell lung cancer patients treated with osimertinib. | Transl Lung Cancer Res | 2020 | https://conductscience.org/library/papers/32420063 | PubMed |
| 32365836 | The Validity and Predictive Value of Blood-Based Biomarkers in Prediction of Response in the Treatment of Metastatic Non-Small Cell Lung Cancer: A Systematic Review. | Cancers (Basel) | 2020 | https://conductscience.org/library/papers/32365836 | PubMed |
| 32206157 | Cell-Free Circulating Tumour DNA Blood Testing to Detect EGFR T790M Mutation in People With Advanced Non-Small Cell Lung Cancer: A Health Technology Assessment. | Ont Health Technol Assess Ser | 2020 | https://conductscience.org/library/papers/32206157 | PubMed |
| 31815659 | Emerging insights of tumor heterogeneity and drug resistance mechanisms in lung cancer targeted therapy. | J Hematol Oncol | 2019 | https://conductscience.org/library/papers/31815659 | PubMed |
| 31433117 | Real-world outcomes of NSCLC patients receiving tissue or circulating tumor DNA-guided osimertinib treatment. | Cancer Med | 2019 | https://conductscience.org/library/papers/31433117 | PubMed |
| 31096692 | Challenges in the Isolation and Proteomic Analysis of Cancer Exosomes-Implications for Translational Research. | Proteomes | 2019 | https://conductscience.org/library/papers/31096692 | PubMed |
Genes1
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes |
|---|---|---|---|
| EGFR | 1956 | PubTator's text mining | https://conductscience.org/library/genes/1956 |
Source NCBI Gene
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/26730486
GET https://conductscience.org/api/papers/v1/26730486/cited_by?page=2